ROHTO PHARMACEUTICAL CO.,LTD.
4527 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 大阪市生野区巽西１丁目８番１号
- Website:
- https://www.rohto.co.jp/global/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
ROHTO Pharmaceutical Co., Ltd. is a pioneering Japanese company dedicated to enhancing global health and well-being. Established over 125 years ago, ROHTO focuses on developing innovative pharmaceuticals and health products that address both physical and mental health needs. The company is committed to sustainability and aims to create new value by connecting with future societal challenges. With a strong emphasis on research and development, ROHTO actively engages in groundbreaking projects, including collaborations in AI and advanced clinical trials. The company's vision, encapsulated in the slogan "Hirake Heart! Hirake ROHTO," reflects its passion for making a positive impact on society. ROHTO continues to strive beyond boundaries, driven by a commitment to improve the lives of individuals worldwide.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-11 04:04 |
Regulatory News Service
訂正確認書
|
Japanese | 9.3 KB | |
| 2025-07-11 04:03 |
Regulatory News Service
訂正有価証券報告書－第89期(2024/04/01－2025/03/31)
|
Japanese | 1.1 MB | |
| 2025-07-01 02:29 |
Inside Information Statement
臨時報告書
|
Japanese | 30.2 KB | |
| 2025-06-25 02:08 |
Internal Control over Financial Reporting
内部統制報告書－第89期(2024/04/01－2025/03/31)
|
Japanese | 26.7 KB | |
| 2025-06-25 02:07 |
Annual Report
有価証券報告書－第89期(2024/04/01－2025/03/31)
|
Japanese | 1.9 MB | |
| 2025-06-25 02:07 |
Regulatory News Service
確認書
|
Japanese | 9.4 KB | |
| 2025-05-12 03:40 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 23.0 KB | |
| 2025-04-14 02:15 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 23.0 KB | |
| 2025-03-14 01:44 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.1 KB | |
| 2025-02-27 03:52 |
Regulatory News Service
訂正臨時報告書
|
Japanese | 37.8 KB | |
| 2025-02-26 08:00 |
Inside Information Statement
臨時報告書
|
Japanese | 44.8 KB | |
| 2025-02-13 02:46 |
Major Shareholding Notification
大量保有報告書
|
Japanese | 38.2 KB | |
| 2024-11-14 02:17 |
Regulatory News Service
確認書
|
Japanese | 9.5 KB | |
| 2024-11-14 02:16 |
Interim Report
半期報告書－第89期(2024/04/01－2025/03/31)
|
Japanese | 290.6 KB | |
| 2024-07-01 08:37 |
Inside Information Statement
臨時報告書
|
Japanese | 28.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |